Levonorgestrel Sameko

Levonorgestrel, the active ingredient in Levonorgestrel Sameko, is a synthetic progestin presented as an oral tablet for oral administration. It works to prevent pregnancy by inhibiting ovulation and altering cervical mucus, and is indicated for emergency contraception and ongoing contraceptive use in women of reproductive age.

GNH USA supplies Levonorgestrel Sameko as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution. Customers benefit from reliable supply chains and responsive technical support.

Levonorgestrel Sameko is a progestin used in contraceptive pathways to prevent unintended pregnancy. - Emergency contraception: prevents pregnancy after unprotected intercourse when taken within the recommended time frame. - Regular contraception: incorporated into hormonal regimens to inhibit ovulation and maintain contraceptive efficacy. - Post‑coital contraception: provides a high dose that interferes with fertilization and implantation.

Levonorgestrel may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Abdominal pain: cramping or lower abdominal discomfort. - Fatigue: feeling unusually tired. - Menstrual changes: spotting, earlier or delayed periods. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes. - Ectopic pregnancy: implantation outside the uterus. - Persistent pelvic pain: may indicate underlying pathology. - Vision changes: rare ocular disturbances.

Before using Levonorgestrel Sameko, consider the following safety measures. - Medical history review: assess for clotting disorders, liver disease, or hormone‑sensitive cancers. - Pregnancy status: avoid use if already pregnant; confirm negative pregnancy test when appropriate. - Breastfeeding: discuss risks with a healthcare professional before use. - Concomitant medications: evaluate potential interactions with enzyme‑inducing drugs. - Thrombosis monitoring: watch for leg swelling, chest pain, or shortness of breath. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levonorgestrel can interact with other medicines, affecting its effectiveness.

Major Interactions (Avoid): - Rifampin: strong enzyme inducer that reduces contraceptive efficacy. - Carbamazepine: decreases plasma levels of levonorgestrel. - Phenytoin: may lower hormonal concentrations. - St. John's wort: herbal inducer that can compromise effectiveness. - Griseofulvin: reduces contraceptive reliability.

Moderate Interactions (Monitor Closely): - Ketoconazole: antifungal that may increase hormone levels. - HIV protease inhibitors: can alter metabolism of levonorgestrel. - Hormonal therapy: combined use may require dosage adjustment. - Antiretroviral agents (e.g., efavirenz): may affect drug levels. - Certain antibiotics (e.g., metronidazole): monitor for reduced efficacy.